NOVACYT (EPA:ALNOV) | WebDisclosure

Basculer en Français

10368	Companies
215965	Keywords
145706	Articles
114373	Press releases

Home
Companies
NOVACYT

PRESS RELEASE

published on 01/30/2025 at 11:03, 1 year 3 months ago

Résultats préliminaires pour l’année 2024
Novacyt annonce des résultats préliminaires solides pour l'année 2024, avec une croissance du chiffre d'affaires et des progrès dans ses activités cliniques, d'instrumentation et de recherche. Mise à jour financière et perspectives prometteuses

Croissance Résultats Préliminaires Perspectives Activités Cliniques Novacyt
BRIEF

published on 12/10/2024 at 11:59, 1 year 4 months ago

Novacyt annonce le déménagement de son siège social

Diagnostic Moléculaire Déménagement D'entreprise Opérations Mondiales Siège Social De Novacyt Médecine Génomique
BRIEF

published on 12/10/2024 at 11:59, 1 year 4 months ago

Novacyt Announces Relocation of Corporate Headquarters

Global Operations Molecular Diagnostics Corporate Relocation Novacyt Headquarters Genomic Medicine
PRESS RELEASE

published on 12/10/2024 at 11:54, 1 year 4 months ago

Changement de siège social
Novacyt announces immediate headquarters relocation to 131 Boulevard Carnot, Le Vésinet, France, reinforcing its position as a global molecular diagnostics company

Headquarters Relocation Paris London Molecular Diagnostics Novacyt
PRESS RELEASE

published on 11/14/2024 at 15:34, 1 year 5 months ago

Expansion du programme de réduction des coûts
Novacyt annonce une consolidation des installations mondiales pour améliorer l'EBITDA. Fermeture du site Eastleigh et transfert des activités de fabrication du Canada à Manchester

EBITDA Consolidation Restructuration Diagnostic Moléculaire Novacyt
PRESS RELEASE

published on 11/14/2024 at 15:31, 1 year 5 months ago

Further expansion of cost reduction programme
Novacyt announces further expansion of cost reduction programme with proposed site consolidations expected to deliver c. £2.0m EBITDA improvement, including closure of Eastleigh site and transfer of Canada manufacturing operations to Manchester

Cost Reduction EBITDA Improvement Manufacturing Operations Novacyt Site Consolidations
BRIEF

published on 11/14/2024 at 15:31, 1 year 5 months ago

Lancement de nouveaux tests vétérinaires par Novacyt

Diagnostic Moléculaire Novacyt Tests Vétérinaires Agents Pathogènes Maladies Gastro-intestinales
BRIEF

published on 11/14/2024 at 15:31, 1 year 5 months ago

Novacyt launches new veterinary tests

Gastrointestinal Diseases Novacyt Molecular Diagnosis Veterinary Tests Pathogens
PRESS RELEASE

published on 11/14/2024 at 15:26, 1 year 5 months ago

Lancement de nouveaux tests multiplexes pour animaux au London Vet Show
Novacyt lance de nouveaux tests multiplexes pour maladies gastro-intestinales chez les chiens et les chats au London Vet Show, offrant des résultats rapides en moins de trois heures

Chiens Novacyt Maladies Gastro-intestinales Tests Multiplexes Chats
BRIEF

published on 11/01/2024 at 14:00, 1 year 6 months ago

Novacyt : Mise à jour sur le contrat de liquidité et les droits de vote

Contrat De Liquidité Droits De Vote INVEST SECURITIES Actions Ordinaires Novacyt

Accesswire

Published on 05/08/2026 at 00:00, 18 minutes ago

Redwood AI Approved to Receive National Research Council of Canada Funding for its Q-SAFE Chemical Screening Project for Defence and Security Applications
Published on 05/07/2026 at 23:30, 48 minutes ago

Faraday Copper Reports First Quarter 2026 Financial Results
Published on 05/07/2026 at 23:15, 1 hour 3 minutes ago

BULGOLD Adopts Semi-Annual Financial Reporting
Published on 05/07/2026 at 22:05, 2 hours 13 minutes ago

MicroVision and Avular Collaborate to Advance Autonomous Sensing and Drone Integration for Next-Generation Infrastructure Applications
Published on 05/07/2026 at 22:05, 2 hours 13 minutes ago

Innodata Reports Record First Quarter 2026 Results

View all ACCESSWIRE

EQS Group

Published on 05/07/2026 at 23:23, 54 minutes ago

H1 25/26: Challenging environment and significant changes in IT market // Revised forecast // Programme to boost competitiveness
Published on 05/07/2026 at 23:14, 1 hour 4 minutes ago

EQS-Adhoc: All for One Group SE revises forecast for 2025/26 financial year // »Precision« programme to boost competitiveness approved
Published on 05/07/2026 at 22:05, 2 hours 13 minutes ago

Univar Solutions Announces Leadership Evolution
Published on 05/07/2026 at 20:42, 3 hours 36 minutes ago

RHÖN-KLINIKUM AG reports stable development in the first quarter of 2026
Published on 05/07/2026 at 18:46, 5 hours 32 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares

Les Echos

Published on 05/07/2026 at 19:15, 5 hours 3 minutes ago

2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 5 hours 3 minutes ago

Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 5 hours 12 minutes ago

Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 5 hours 12 minutes ago

Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 5 hours 18 minutes ago

ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL

View all LES ECHOS COMFI WIRE